Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.

非那雄胺 医学 特拉唑嗪 泌尿科 就寝时间 前列腺 增生 内科学 癌症
作者
A K M Anwarul Islam,Md. Abul Kashem,I A Shameem,S A M G Kibria
出处
期刊:Bangladesh Medical Research Council Bulletin [Bangladesh Journals Online]
卷期号:31 (2): 54-61 被引量:3
标识
摘要

Medical treatment for symptomatic Benign Prostatic Hyperplasia (BPH) has become popular for the last few years. This study was designed to find out and compare the efficacy of terazosin, a alpha1 adrenoceptor blocker and finasteride, a 5alpha-reductase inhibitor in symptomatic BPH. A total of 60 patients (30 in terazosin group and 30 finasteride group) of symptomatic BPH were selected. Terazosin group received 1 mg daily at bedtime for 3 days, 2 mg at bedtime for 7 days, thereafter 5 mg at bedtime daily for 6 months. Finasteride group received 5 mg once daily. In terazosin treated patients, improvement after 3 months were as follows, IPSS 3.93 +/- .74 points reduction, Qmax 2.13 +/- .68 ml/s increase, post-voided residual urine volume (PVR) 20.67 +/- 10.56 ml reduction (significant, p<0.001) and prostate volume 0.57 +/- 1.54 ml reduction (not significant). Similar statistical differences were observed at 6 months follow up. In finasteride treated patients, improvements after 3 months were as follows, International Prostate Symptom Score (IPSS) 1.38 +/- .63 points reduction, Qmax 0.55 +/- 0.78 ml/s increase, PVR 5.93 +/- 7.64 ml reduction (significant, p<0.001) and prostate volume 0.17 +/- 5.6 ml reduction (non-significant). At 6 month follow up statistical differences were significant in all parameters including prostate volume 4.57 +/- 5.30 ml reduction (p<0.001). In comparison, statistically significant superiority of terazosin over finasteride was found in improving IPSS, Qmax and PVR in both follow up visits. But terazosin had nonsignificant effect in reducing prostate volume; in contrast, finasteride had significant effect in second visit. It can be concluded from this study that terazosin 5mg once daily is effective in mild to moderate cases of symptomatic BPH. On the other hand, finasteride 5mg once daily may be useful in large prostate and to be given for at least 6 months.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
fan完成签到,获得积分10
1秒前
zhang完成签到,获得积分20
3秒前
北彧发布了新的文献求助10
3秒前
松鼠发布了新的文献求助10
3秒前
yang发布了新的文献求助10
4秒前
简单完成签到,获得积分10
4秒前
4秒前
shinble发布了新的文献求助50
4秒前
糊涂的访烟完成签到,获得积分10
4秒前
南音发布了新的文献求助10
5秒前
澡雪发布了新的文献求助10
5秒前
所所应助fan采纳,获得10
8秒前
传奇3应助科研通管家采纳,获得10
8秒前
NexusExplorer应助科研通管家采纳,获得10
8秒前
斯文败类应助科研通管家采纳,获得50
8秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
SciGPT应助科研通管家采纳,获得10
9秒前
jyy应助科研通管家采纳,获得10
9秒前
共享精神应助科研通管家采纳,获得10
9秒前
jyy应助科研通管家采纳,获得10
9秒前
FashionBoy应助迷路的鞅采纳,获得10
9秒前
所所应助科研通管家采纳,获得30
9秒前
9秒前
9秒前
9秒前
sukuyo发布了新的文献求助10
9秒前
钉钉完成签到 ,获得积分10
10秒前
10秒前
深情安青应助北彧采纳,获得10
11秒前
天天快乐应助松鼠采纳,获得10
11秒前
tao完成签到,获得积分10
11秒前
Orange应助奋斗的忆南采纳,获得10
11秒前
幽灵离殇完成签到,获得积分10
12秒前
12秒前
12秒前
13秒前
14秒前
科研通AI2S应助李治稳采纳,获得10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975722
求助须知:如何正确求助?哪些是违规求助? 3520056
关于积分的说明 11200719
捐赠科研通 3256455
什么是DOI,文献DOI怎么找? 1798271
邀请新用户注册赠送积分活动 877490
科研通“疑难数据库(出版商)”最低求助积分说明 806390